Name Net reduced
positions
Reduced positions Increased positions Return since
30 Sep ‘15
201
6 39 33 199%
202
6 28 22 5.33%
203
6 63 57 50.3%
LCTX icon
204
Lineage Cell Therapeutics
LCTX
$377M
6 24 18 31.8%
205
6 15 9 45.4%
206
6 11 5 21.7%
207
6 17 11 92.6%
208
6 35 29 54.2%
209
6 24 18 34.9%
210
6 19 13 507%
PRGS icon
211
Progress Software
PRGS
$1.94B
6 65 59 74.8%
212
6 76 70 24.1%
213
6 12 6 99.3%
214
6 11 5 60.1%
215
6 17 11 237%
216
6 83 77 24%
217
6 50 44 98.1%
218
6 16 10 58%
219
6 12 6 65%
220
6 34 28 31.8%
221
6 21 15 18.7%
222
6 22 16 45.8%
223
6 16 10 810%
224
6 8 2 468%
225
6 12 6 31.9%